Molecular Determinants of Resistance to Antiandrogen Therapy

No abstract is available for this paper.

• Publication year

  2004

• Venue

  The Journal of Urology

• Publication date

  2004-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.JU.0000141478.13478.C3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Androgen receptor outwits prostate cancer drugs

  2004cited by this paper

• Resistance to the Androgen Receptor Centred Therapies: Biology and Management

  2021cites this paper
• Construction of Potential Gene Expression and Regulation Networks in Prostate Cancer Using Bioinformatics Tools

  2021cites this paper
• Role of androgen receptor splice variant 7 (AR-V7) in prostate cancer resistance to 2nd generation androgen receptor signaling inhibitors

  2020cites this paper
• Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate Cancer

  2020cites this paper
• Convergent evolution of p38/MAPK activation in hormone resistant prostate cancer mediates pro-survival, immune evasive, and metastatic phenotypes

  2020influential citation
• LOSS OF THE TUMOR SUPPRESSOR, TP53, ENHANCES THE ANDROGEN RECEPTOR MEDIATED ONCOGENIC TRANSFORMATION AND TUMOR DEVELOPMENT IN THE MOUSE PROSTATE

  2019cites this paper
• PlexinB1 Promotes Nuclear Translocation of the Glucocorticoid Receptor

  2019cites this paper
• Adrenals Contribute to Growth of Castration-Resistant VCaP Prostate Cancer Xenografts.

  2018cites this paper
• Interference with the androgen receptor protein stability in therapy‐resistant prostate cancer

  2018cites this paper
• A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer

  2018cites this paper
• Regulation of the glucocorticoid receptor in prostate cancer disease progression and resistance to anti-androgen therapy

  2017cites this paper
• Role of androgen receptor splice variants in prostate cancer metastasis

  2016cites this paper
• TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling

  2015cites this paper
• Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells

  2013cites this paper
• Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor‐axis in castration‐resistant prostate tumors

  2012cites this paper
• A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo

  2012cites this paper
• Darinaparsin: Solid Tumor Hypoxic Cytotoxin and Radiosensitizer

  2012cites this paper
• Translating Scientific Advancement into Clinical Benefit for Castration-Resistant Prostate Cancer Patients

  2011cites this paper
• Differential expression of estrogen‐related receptors β and γ (ERRβ and ERRγ) and their clinical significance in human prostate cancer

  2010cites this paper
• Characterization of Myopathy in Mice Overexpressing Androgen Receptor in Skeletal Muscle

  2010cites this paper
• Mechanisms of prostate cancer cell survival after inhibition of AR expression

  2009cites this paper
• Inhibition of androgen receptor transcriptional activity as a novel mechanism of action of arsenic.

  2009cites this paper
• Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells.

  2009cites this paper
• Molecular Mechanisms of Androgen Receptor Interactions

  2006cites this paper